RANDY PARDELL: Open Payments
NPI 1578516969 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 45 payments from 7 companies in 2025. Trend: 2023 $457 · 2024 $2,239 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $353 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Alkermes, Inc. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Corium, LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: VRAYLAR, COBENFY, INGREZZA, LYBALVI, CAPLYTA, Azstarys, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
